Production (Stage)
FibroBiologics, Inc.
FBLG
$0.8087
-$0.0638-7.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.67M | -11.16M | -17.78M | -19.47M | -22.53M |
| Total Depreciation and Amortization | 597.00K | 573.00K | 550.00K | 519.00K | 478.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 3.00K |
| Total Other Non-Cash Items | -4.42M | -1.87M | 5.64M | 8.29M | 12.24M |
| Change in Net Operating Assets | -1.42M | 559.00K | 1.16M | 1.70M | 1.17M |
| Cash from Operations | -12.90M | -11.90M | -10.43M | -8.96M | -8.64M |
| Capital Expenditure | -219.00K | -184.00K | -87.00K | -489.00K | -447.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -219.00K | -184.00K | -87.00K | -489.00K | -447.00K |
| Total Debt Issued | 9.40M | 9.97M | 574.00K | 574.00K | 574.00K |
| Total Debt Repaid | -459.00K | -574.00K | -459.00K | -287.00K | -115.00K |
| Issuance of Common Stock | 4.69M | 7.51M | 7.46M | 2.82M | 2.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 940.00K | 11.25M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -12.02M |
| Cash from Financing | 13.63M | 16.91M | 7.58M | 4.05M | 2.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 509.00K | 4.82M | -2.94M | -5.41M | -6.58M |